{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:43Z","timestamp":1790700583819,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.clon.2009.05.005","type":"journal-article","created":{"date-parts":[[2009,6,29]],"date-time":"2009-06-29T04:03:51Z","timestamp":1246248231000},"page":"557-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Radiochemotherapy for Bladder Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"O.J.","family":"Ott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wittlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"St. Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Dunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2009.05.005_bib1","series-title":"World cancer report 2008","author":"World Health Organization","year":"2008"},{"key":"10.1016\/j.clon.2009.05.005_bib2","series-title":"World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organs","author":"Eble","year":"2004"},{"key":"10.1016\/j.clon.2009.05.005_bib3","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/sonc.2001.21961","article-title":"Bladder cancer in Africa: update","volume":"28","author":"el-Mawla","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.1464-410X.1996.09310.x","article-title":"Bladder cancer in various population groups in the greater Durban area of KwaZulu-Natal, South Africa","volume":"78","author":"Groeneveld","year":"1996","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib5","first-page":"202","article-title":"Bladder cancer in Kano\u2014a histopathological review","volume":"22","author":"Ochicha","year":"2003","journal-title":"West Afr J Med"},{"key":"10.1016\/j.clon.2009.05.005_bib6","first-page":"36","volume":"16","author":"Sow","year":"2006","journal-title":"Prog Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M","article-title":"Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies","volume":"86","author":"Brennan","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clon.2009.05.005_bib8","first-page":"411","article-title":"The contribution of cigarette smoking to bladder cancer in women (pooled European data)","volume":"12","author":"Brennan","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clon.2009.05.005_bib9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1289\/ehp.7047","article-title":"Listing occupational carcinogens","volume":"112","author":"Siemiatycki","year":"2004","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.clon.2009.05.005_bib10","series-title":"IARC monographs on the evaluation of the carcinogenic risk to humans. Supplement 7. Overall evaluation of carcinogenicity: an updating of IARC monographs Volumes 1 to 42","author":"International Agency for Research on Cancer","year":"2008"},{"key":"10.1016\/j.clon.2009.05.005_bib11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10067-004-1032-2","article-title":"Cyclophosphamide is contraindicated in patients with a history of transitional cell carcinoma","volume":"24","author":"Volkmer","year":"2005","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.clon.2009.05.005_bib12","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/bjc.1998.197","article-title":"Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt","volume":"77","author":"Bedwani","year":"1998","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clon.2009.05.005_bib13","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1002\/ijc.21731","article-title":"The global health burden of infection-associated cancers in the year 2002","volume":"118","author":"Parkin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clon.2009.05.005_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ncpuro0510","article-title":"Mechanisms of disease: the epidemiology of bladder cancer","volume":"3","author":"Pelucchi","year":"2006","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib15","author":"Commission on Cancer\/American Cancer Society"},{"key":"10.1016\/j.clon.2009.05.005_bib16","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/0959-8049(94)90472-3","article-title":"Bladder cancer incidence and survival in the south-eastern part of The Netherlands, 1975\u20131989","volume":"30A","author":"Kiemeney","year":"1994","journal-title":"Eur J Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.clon.2009.05.005_bib17","doi-asserted-by":"crossref","first-page":"v150","DOI":"10.1093\/annonc\/mdg757","article-title":"Electronic availability of EUROCARE-3 data: a tool for further analysis","volume":"14","author":"Roazzi","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib18","author":"Babjuk"},{"key":"10.1016\/j.clon.2009.05.005_bib19","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"Rodel","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib20","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S0022-5347(17)39122-X","article-title":"Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis","volume":"142","author":"Gospodarowicz","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1055\/s-2008-1038150","article-title":"Radiochemotherapeutic options for bladder cancer","volume":"39","author":"Weiss","year":"2008","journal-title":"Aktuelle Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib22","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1200\/JCO.2006.05.8149","article-title":"Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy?","volume":"24","author":"Weiss","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib23","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/1097-0142(19900215)65:4<908::AID-CNCR2820650415>3.0.CO;2-Z","article-title":"Prognostic factors in patients with bladder carcinoma treated with definitive irradiation","volume":"65","author":"Greven","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.clon.2009.05.005_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0360-3016(98)00263-6","article-title":"Muscle-invasive bladder cancer treated with external beam radiation: influence of total dose, overall treatment time, and treatment interruption on local control","volume":"42","author":"Moonen","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0167-8140(86)80060-3","article-title":"Prognostic indices for bladder cancer: an analysis of patients with transitional cell carcinoma of the bladder primarily treated by radical megavoltage X-ray therapy","volume":"7","author":"Quilty","year":"1986","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1464-410X.1991.tb15071.x","article-title":"Radical radiation treatment of invasive and locally advanced bladder carcinoma in elderly patients","volume":"67","author":"Smaaland","year":"1991","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0360-3016(94)90004-3","article-title":"Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors","volume":"30","author":"Pollack","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0022-5347(17)47381-2","article-title":"Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival","volume":"134","author":"Shipley","year":"1985","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib29","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ijrobp.2005.09.023","article-title":"Radical radiotherapy for invasive bladder cancer: what dose and fractionation schedule to choose?","volume":"64","author":"Pos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3109\/02841869409098435","article-title":"Hyperfractionated radiotherapy of bladder cancer. A ten-year follow-up of a randomized clinical trial","volume":"33","author":"Naslund","year":"1994","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib31","first-page":"14","volume":"36","author":"Goldobenko","year":"1991","journal-title":"Med Radiol (Mosk)"},{"key":"10.1016\/j.clon.2009.05.005_bib32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0360-3016(96)00511-1","article-title":"Hyperfractionated radiotherapy of human tumors: overview of the randomized clinical trials","volume":"37","author":"Stuschke","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0167-8140(91)90033-D","article-title":"Dose fractionation and tumour repopulation in radiotherapy for bladder cancer","volume":"21","author":"Maciejewski","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib34","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2004.11.003","article-title":"A randomised trial of accelerated radiotherapy for localised invasive bladder cancer","volume":"75","author":"Horwich","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib35","first-page":"673","volume":"161","author":"Kob","year":"1985","journal-title":"Strahlentherapie"},{"key":"10.1016\/j.clon.2009.05.005_bib36","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.10.023","article-title":"Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy","volume":"64","author":"Hata","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ijrobp.2005.09.044","article-title":"X-ray volume imaging in bladder radiotherapy verification","volume":"64","author":"Henry","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ijrobp.2004.06.249","article-title":"Organ preservation in invasive bladder cancer: brachytherapy, an alternative to cystectomy and combined modality treatment?","volume":"61","author":"Pos","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib39","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ijrobp.2005.07.976","article-title":"Adaptive radiotherapy for invasive bladder cancer: a feasibility study","volume":"64","author":"Pos","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0167-8140(95)01586-6","article-title":"Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment time","volume":"36","author":"De Neve","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1464-410X.1988.tb04362.x","article-title":"Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive (T2\/T3) bladder cancer","volume":"62","author":"Jenkins","year":"1988","journal-title":"Br J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib42","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0360-3016(94)E0135-7","article-title":"Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder","volume":"31","author":"Mameghan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib43","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1200\/JCO.2006.07.6729","article-title":"Trimodality treatment and selective organ preservation for bladder cancer","volume":"24","author":"Rodel","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib44","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.1996.14.11.2901","article-title":"Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group","volume":"14","author":"Coppin","year":"1996","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clon.2009.05.005_bib45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.ijrobp.2007.01.054","article-title":"Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer","volume":"Jul 15; 68","author":"Weiss","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 3","key":"10.1016\/j.clon.2009.05.005_bib46","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF03215920","article-title":"Preliminary results of simultaneous radiochemotherapy with paclitaxel for urinary bladder cancer","volume":"175","author":"Dunst","year":"1999","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"10.1016\/j.clon.2009.05.005_bib47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.urology.2008.09.036","article-title":"Phase I\u2013II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy","volume":"Apr;73","author":"Kaufman","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.clon.2009.05.005_bib48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00066-007-1651-z","article-title":"Organ-sparing treatment of advanced bladder cancer: paclitaxel as a radiosensitizer","volume":"183","author":"Muller","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clon.2009.05.005_bib49","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/1097-0215(20001020)90:5<281::AID-IJC5>3.0.CO;2-U","article-title":"Radiation therapy and concomitant paclitaxel\/carboplatin chemotherapy for muscle invasive transitional cell carcinoma of the bladder: a well-tolerated combination","volume":"90","author":"Nichols","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.clon.2009.05.005_bib50","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.ijrobp.2005.01.004","article-title":"A single institution experience with concurrent capecitabine and radiation therapy in weak and\/or elderly patients with urothelial cancer","volume":"62","author":"Patel","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.clon.2009.05.005_bib51","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ijrobp.2008.08.021","article-title":"Combined-modality therapy with gemcitabine and radiation therapy as a bladder preservation strategy: long-term results of a phase I trial","volume":"Jun 1;74","author":"Oh","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ijrobp.2004.05.074","article-title":"Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer","volume":"61","author":"Sangar","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib53","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0360-3016(03)00763-6","article-title":"Phase I study of gemcitabine and radiotherapy plus cisplatin after transurethral resection as conservative treatment for infiltrating bladder cancer","volume":"57","author":"Caffo","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib54","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/annonc\/mdf280","article-title":"Heating the patient: a promising approach?","volume":"13","author":"van der Zee","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib55","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1470-2045(02)00818-5","article-title":"Hyperthermia in combined treatment of cancer","volume":"3","author":"Wust","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib56","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.clon.2007.03.015","article-title":"Hyperthermia: a potent enhancer of radiotherapy","volume":"19","author":"Horsman","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clon.2009.05.005_bib57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/02656730701772480","article-title":"The role of hyperthermia in optimizing tumor response to regional therapy","volume":"24","author":"Moyer","year":"2008","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.clon.2009.05.005_bib58","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1200\/JCO.2003.01.089","article-title":"Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma","volume":"21","author":"Colombo","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib59","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(00)02059-6","article-title":"Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group","volume":"355","author":"van der Zee","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.clon.2009.05.005_bib60","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0360-3016(94)90003-5","article-title":"Organ-sparing treatment of advanced bladder cancer: a 10-year experience","volume":"30","author":"Dunst","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib61","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0360-3016(97)00579-8","article-title":"Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer","volume":"40","author":"Sauer","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib62","volume":"vol. VIII","author":"International Agency for Research on Cancer","year":"2002"},{"key":"10.1016\/j.clon.2009.05.005_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2008.11.030","article-title":"Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer","author":"Lin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2009.05.005_bib64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","article-title":"Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients","volume":"19","author":"Stein","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib65","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-5347(05)66440-3","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2003.05.101","article-title":"Radical cystectomy for bladder cancer today\u2014a homogeneous series without neoadjuvant therapy","volume":"21","author":"Madersbacher","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2009.05.005_bib67","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.juro.2006.03.038","article-title":"Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era","volume":"176","author":"Hautmann","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.clon.2009.05.005_bib68","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.juro.2006.08.004","article-title":"Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium","volume":"176","author":"Shariat","year":"2006","journal-title":"J Urol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655509001502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:34:57Z","timestamp":1760542497000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655509001502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":68,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0936655509001502"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2009.05.005","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiochemotherapy for Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2009.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}